Clinical TrialsSearch results
Number of results: 972
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase II study of rituximab in patients with severe systemic lupus erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Other
- Phase II study of Rituximab in Patients with Systemic Lupus Erythematosus
- Systemic lupus erythematosus
- Zenyaku Kogyo Co., Ltd.
- 2007-07-05
Other
- Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20
- Multiple myeloma expressing CD20
- Zenyaku Kogyo Co., Ltd.
- 2006-11-28
Completed
- A phase II continuous clinical trial of peptide vaccination for cancer patients
- Malignant Tumor
- Yutani Shigeru
- 2019-03-19
Other
- A randomized phase III trial of postoperative adjuvant oral fluoropyrimidine vs. sequential paclitaxel / oral fluoropyrimidine; and UFT vs. S1 for T3 / T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (SAMIT) Trial
- Gastric Cancer
- Young Leaders' Program (YLP), Nagoya University School of Medicine
- 2005-09-01
Recruiting
- A MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED, DOUBLE-BLIND PHASE III CLINICAL TRIAL OF OBINUTUZUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
- systemic lupus erythematosus
- Yoshiya Tanaka
- 2023-06-25
Other
- Safety of Early Exercise Training in Patients Underwent Elective Coronary Stenting
- stable angina
- Yoshimitsu Soga
- 2009-05-10
Other
- Combination of SGLT2 inhibitor and Intensive Exercise in Diabetes.
- type 2 diabetes
- Yoshihiro Ogawa
- 2019-03-15
Completed
- Effects of microbiome from probiotics and fermented foods on the pharmacokinetics of orally administered drugs
- healthy male
- Yoshihara Tatsuya
- 2023-08-28
Completed
- Influence of therapeutic agent for glaucoma on biological clock
- Healthy
- Yoshihara Tatsuya
- 2019-02-28